Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Aurobindo Phar Aurobindo Pharma Ltd. | BSE 1143.70 22.05 (1.97%) | NSE 1145.30 23.60 (2.10%) | Trade | Add

BSE Live

Jan 22, 16:01

1143.70 22.05 (1.97%)

Volume

AVERAGE VOLUME

5-Day

10,994

10-Day

20,093

30-Day

23,287

4,712

Prev. Close

1121.65
Open Price

1123.85

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 22, 15:59

1145.30 23.60 (2.10%)

Volume

AVERAGE VOLUME

5-Day

711,947

10-Day

923,406

30-Day

803,557

622,804

Prev. Close

1121.70
Open Price

1130.10

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1145.30 (143)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Aurobindo Pharma (in Rs. Cr.)	Mar 10	Mar 09	Mar 08	Mar 07	Mar 06
Per Share Ratios
Basic EPS (Rs.)	101.11	18.65	44.36	37.64	13.09
Diluted EPS (Rs.)	101.11	18.65	44.36	37.64	13.09
Cash EPS (Rs.)	127.86	42.38	62.96	56.54	26.90
Book Value [ExclRevalReserve]/Share (Rs.)	329.04	231.48	209.67	166.77	153.45
Book Value [InclRevalReserve]/Share (Rs.)	329.04	231.48	209.67	166.77	153.45
Revenue from Operations/Share (Rs.)	646.85	572.42	451.32	395.82	297.08
PBDIT/Share (Rs.)	171.58	52.42	78.41	63.67	37.41
PBIT/Share (Rs.)	144.78	28.69	59.75	44.97	23.87
PBT/Share (Rs.)	133.56	13.33	53.07	37.71	11.95
Net Profit/Share (Rs.)	101.06	18.64	44.30	37.85	13.36
NP After MI And SOA / Share (Rs.)	101.11	18.65	44.36	37.64	13.09
Profitability Ratios
PBDIT Margin (%)	26.52	9.15	17.37	16.08	12.59
PBIT Margin (%)	22.38	5.01	13.23	11.36	8.03
PBT Margin (%)	20.64	2.32	11.75	9.52	4.02
Net Profit Margin (%)	15.62	3.25	9.81	9.56	4.49
NP After MI And SOA Margin (%)	15.63	3.25	9.82	9.51	4.40
Return on Networth/Equity (%)	30.80	8.07	21.21	22.66	8.55
Return on Capital Employed (%)	28.13	5.95	13.18	9.95	7.41
Return on Assets (%)	11.75	2.37	6.56	5.72	2.59
Total Debt/Equity (X)	1.18	1.88	1.64	2.35	1.69
Asset Turnover Ratio (%)	0.80	0.78	0.68	0.68	0.00
Liquidity Ratios
Current Ratio (X)	1.30	1.40	1.72	1.95	1.49
Quick Ratio (X)	0.73	0.86	1.06	1.35	1.01
Inventory Turnover Ratio (X)	2.12	2.16	2.10	2.49	0.00
Dividend Payout Ratio (NP) (%)	4.92	24.13	7.36	6.64	11.64
Dividend Payout Ratio (CP) (%)	3.89	10.62	5.18	4.43	5.72
Earnings Retention Ratio (%)	95.08	75.87	92.64	93.36	88.36
Cash Earnings Retention Ratio (%)	96.11	89.38	94.82	95.57	94.28
Coverage Ratios
Interest Coverage Ratios (%)	15.30	3.41	11.73	8.76	3.14
Interest Coverage Ratios (Post Tax) (%)	15.30	3.41	11.73	8.76	3.14
Valuation Ratios
Enterprise Value (Cr.)	7,428.49	3,229.37	3,133.95	5,121.81	4,809.90
EV/Net Operating Revenue (X)	2.06	1.05	1.29	2.43	3.04
EV/EBITDA (X)	7.77	11.46	7.43	15.08	24.14
MarketCap/Net Operating Revenue (X)	1.48	0.33	0.65	1.72	2.30
Retention Ratios (%)	95.07	75.86	92.63	93.35	88.35
Price/BV (X)	2.92	0.82	1.39	4.09	4.46
Price/Net Operating Revenue	1.48	0.33	0.65	1.72	2.30
Earnings Yield	0.11	0.10	0.15	0.06	0.02